Schering Plough's alpha interferon research
Executive Summary
Firm has submitted NDAs for the use of alpha interferon in the treatment of malignant melonoma, Kaposi's sarcoma and multiple myeloma. "The Pink Sheet" (Nov. 5, p. 7) incorrectly reported an NDA was pending for use in multiple melonoma.